- Home
- CBLL vs LAB Comparison
CBLL vs LAB Comparison
Compare CBLL & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- LAB
- Stock Information
- Founded
- CBLL 2014
- LAB 1999
- Country
- CBLL United States
- LAB United States
- Employees
- CBLL N/A
- LAB N/A
- Industry
- CBLL
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- CBLL
- LAB Industrials
- Exchange
- CBLL Nasdaq
- LAB Nasdaq
- Market Cap
- CBLL 538.0M
- LAB 451.0M
- IPO Year
- CBLL 2024
- LAB 2011
- Fundamental
- Price
- CBLL $16.81
- LAB $1.01
- Analyst Decision
- CBLL Strong Buy
- LAB Buy
- Analyst Count
- CBLL 6
- LAB 2
- Target Price
- CBLL $33.00
- LAB $2.50
- AVG Volume (30 Days)
- CBLL 342.3K
- LAB 1.6M
- Earning Date
- CBLL 05-08-2025
- LAB 05-06-2025
- Dividend Yield
- CBLL N/A
- LAB N/A
- EPS Growth
- CBLL N/A
- LAB N/A
- EPS
- CBLL N/A
- LAB N/A
- Revenue
- CBLL $71,535,000.00
- LAB $169,687,000.00
- Revenue This Year
- CBLL $34.12
- LAB N/A
- Revenue Next Year
- CBLL $28.66
- LAB $12.18
- P/E Ratio
- CBLL N/A
- LAB N/A
- Revenue Growth
- CBLL 44.86
- LAB 33.86
- 52 Week Low
- CBLL $10.01
- LAB $0.92
- 52 Week High
- CBLL $32.75
- LAB $2.65
- Technical
- Relative Strength Index (RSI)
- CBLL N/A
- LAB 44.66
- Support Level
- CBLL N/A
- LAB $1.00
- Resistance Level
- CBLL N/A
- LAB $1.09
- Average True Range (ATR)
- CBLL 0.00
- LAB 0.08
- MACD
- CBLL 0.00
- LAB -0.00
- Stochastic Oscillator
- CBLL 0.00
- LAB 33.33
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.